317 related articles for article (PubMed ID: 33987657)
1. Increasing LRP4 diminishes neuromuscular deficits in a mouse model of Duchenne muscular dystrophy.
Hui T; Jing H; Zhou T; Chen P; Liu Z; Dong X; Yan M; Ren D; Zou S; Wang S; Fei E; Hong D; Lai X
Hum Mol Genet; 2021 Aug; 30(17):1579-1590. PubMed ID: 33987657
[TBL] [Abstract][Full Text] [Related]
2. Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models.
van der Pijl EM; van Putten M; Niks EH; Verschuuren JJ; Aartsma-Rus A; Plomp JJ
Eur J Neurosci; 2016 Jun; 43(12):1623-35. PubMed ID: 27037492
[TBL] [Abstract][Full Text] [Related]
3. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
4. Sarcoglycan Alpha Mitigates Neuromuscular Junction Decline in Aged Mice by Stabilizing LRP4.
Zhao K; Shen C; Li L; Wu H; Xing G; Dong Z; Jing H; Chen W; Zhang H; Tan Z; Pan J; Xiong L; Wang H; Cui W; Sun XD; Li S; Huang X; Xiong WC; Mei L
J Neurosci; 2018 Oct; 38(41):8860-8873. PubMed ID: 30171091
[TBL] [Abstract][Full Text] [Related]
5. Alterations of neuromuscular junctions in Duchenne muscular dystrophy.
Lovering RM; Iyer SR; Edwards B; Davies KE
Neurosci Lett; 2020 Oct; 737():135304. PubMed ID: 32818587
[TBL] [Abstract][Full Text] [Related]
6. Imaging Analysis of the Neuromuscular Junction in Dystrophic Muscle.
Pratt SJP; Iyer SR; Shah SB; Lovering RM
Methods Mol Biol; 2018; 1687():57-72. PubMed ID: 29067656
[TBL] [Abstract][Full Text] [Related]
7. Muscle specific kinase protects dystrophic mdx mouse muscles from eccentric contraction-induced loss of force-producing capacity.
Trajanovska S; Ban J; Huang J; Gregorevic P; Morsch M; Allen DG; Phillips WD
J Physiol; 2019 Sep; 597(18):4831-4850. PubMed ID: 31340406
[TBL] [Abstract][Full Text] [Related]
8. Truncated dystrophins can influence neuromuscular synapse structure.
Banks GB; Chamberlain JS; Froehner SC
Mol Cell Neurosci; 2009 Apr; 40(4):433-41. PubMed ID: 19171194
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
10. Recovery of altered neuromuscular junction morphology and muscle function in mdx mice after injury.
Pratt SJP; Shah SB; Ward CW; Kerr JP; Stains JP; Lovering RM
Cell Mol Life Sci; 2015 Jan; 72(1):153-64. PubMed ID: 24947322
[TBL] [Abstract][Full Text] [Related]
11. The collagen ColQ binds to LRP4 and regulates the activation of the Muscle-Specific Kinase-LRP4 receptor complex by agrin at the neuromuscular junction.
Uyen Dao TM; Barbeau S; Messéant J; Della-Gaspera B; Bouceba T; Semprez F; Legay C; Dobbertin A
J Biol Chem; 2023 Aug; 299(8):104962. PubMed ID: 37356721
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Inhibition of PKCθ Counteracts Muscle Disease in a Mouse Model of Duchenne Muscular Dystrophy.
Marrocco V; Fiore P; Benedetti A; Pisu S; Rizzuto E; Musarò A; Madaro L; Lozanoska-Ochser B; Bouché M
EBioMedicine; 2017 Feb; 16():150-161. PubMed ID: 28089792
[TBL] [Abstract][Full Text] [Related]
13. LRP4 is critical for neuromuscular junction maintenance.
Barik A; Lu Y; Sathyamurthy A; Bowman A; Shen C; Li L; Xiong WC; Mei L
J Neurosci; 2014 Oct; 34(42):13892-905. PubMed ID: 25319686
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of Dystrophin-Positive Muscle Fibers and Improvement of Neuromuscular Junctions in mdx Mouse Muscles after Bone Marrow Transplantation under Different Conditions.
Sokolova AV; Domnina AP; Mikhailov VM
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240237
[TBL] [Abstract][Full Text] [Related]
15. Muscle-specific overexpression of IGF-I improves E-C coupling in skeletal muscle fibers from dystrophic mdx mice.
Schertzer JD; van der Poel C; Shavlakadze T; Grounds MD; Lynch GS
Am J Physiol Cell Physiol; 2008 Jan; 294(1):C161-8. PubMed ID: 17989207
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms and Consequences of Cerebellar Purkinje Cell Disinhibition in a Mouse Model of Duchenne Muscular Dystrophy.
Wu WC; Bradley SP; Christie JM; Pugh JR
J Neurosci; 2022 Mar; 42(10):2103-2115. PubMed ID: 35064002
[TBL] [Abstract][Full Text] [Related]
17. Enhanced dimethylarginine degradation improves coronary flow reserve and exercise tolerance in Duchenne muscular dystrophy carrier mice.
Garbincius JF; Merz LE; Cuttitta AJ; Bayne KV; Schrade S; Armstead EA; Converso-Baran KL; Whitesall SE; D'Alecy LG; Michele DE
Am J Physiol Heart Circ Physiol; 2020 Sep; 319(3):H582-H603. PubMed ID: 32762558
[TBL] [Abstract][Full Text] [Related]
18. Effects of in vivo injury on the neuromuscular junction in healthy and dystrophic muscles.
Pratt SJP; Shah SB; Ward CW; Inacio MP; Stains JP; Lovering RM
J Physiol; 2013 Jan; 591(2):559-70. PubMed ID: 23109110
[TBL] [Abstract][Full Text] [Related]
19. Striated muscle activator of Rho signalling (STARS) overexpression in the mdx mouse enhances muscle functional capacity and regulates the actin cytoskeleton and oxidative phosphorylation pathways.
Sadler KJ; Gatta PAD; Naim T; Wallace MA; Lee A; Zaw T; Lindsay A; Chung RS; Bello L; Pegoraro E; Lamon S; Lynch GS; Russell AP
Exp Physiol; 2021 Jul; 106(7):1597-1611. PubMed ID: 33963617
[TBL] [Abstract][Full Text] [Related]
20. Increasing taurine intake and taurine synthesis improves skeletal muscle function in the mdx mouse model for Duchenne muscular dystrophy.
Terrill JR; Pinniger GJ; Graves JA; Grounds MD; Arthur PG
J Physiol; 2016 Jun; 594(11):3095-110. PubMed ID: 26659826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
